Eli Lilly: how much of the obesity boom is left?
Revenue is up 48% and guidance has been raised twice this year, but prices are falling as fast as volumes are climbing. An Amber first look at what has to keep going right.
Oct 12, 2026
Revenue is up 48% and guidance has been raised twice this year, but prices are falling as fast as volumes are climbing. An Amber first look at what has to keep going right.
Oct 12, 2026
Haverhill Financial Research publishes general, impersonal financial research for educational purposes only. Nothing on this site or in our newsletters is personalized investment advice or a recommendation to buy or sell any security for your specific situation. Do your own research and consider consulting a licensed professional before investing. Authors may hold positions in securities discussed; positions are disclosed in each issue.
Questions or customer inquiries: [email protected]
© 2026 Haverhill Financial Research